Maria F. Pires
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria F. Pires has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Dario A. Vitturi
Department of Pathology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA
2 shared publications - Francisco Jose Schopfer
Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
2 shared publications - Mara Carreño
Department of Pathology, School of Medicine, the University of Alabama at Birmingham, Birmingham, AL
2 shared publications - Samit Ghosh
Department of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
2 shared publications - Sonia R. Salvatore
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
2 shared publications - Adam C. Straub
Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA; Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, USA; Center for Microvascular Research, University of Pittsburgh, Pittsburgh, PA, USA
1 shared publication
Latest Publications
- Open Access
- 11 June 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (12) , 2886-2890
Nitrated fatty acids protect against acute kidney injury in sickle cell disease
- 11 June 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (12) , 2886-2890
Open AccessNitrated fatty acids protect against acute kidney injury in sickle cell disease
- Open Access
- 1 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (26) , eabm9138
Immunomodulatory actions of a kynurenine-derived endogenous electrophile
The up-regulation of kynurenine metabolism induces immunomodulatory responses via incompletely understood mechanisms. We report that increases in cellular and systemic kynurenine levels yield the electrophilic derivative kynurenine-carboxyketoalkene (Kyn-CKA), as evidenced by the accumulation of thiol conjugates and saturated metabolites. Kyn-CKA induces NFE2 like bZIP transcription factor 2– and aryl hydrocarbon receptor–regulated genes and inhibits nuclear factor κB– and NLR family pyrin domain containing 3-dependent proinflammatory signaling. Sickle cell disease (SCD) is a hereditary hemolytic condition characterized by basal inflammation and recurrent vaso-occlusive crises. Both transgenic SCD mice and patients with SCD exhibit increased kynurenine and Kyn-CKA metabolite levels. Plasma hemin and kynurenine concentrations are positively correlated, indicating that Kyn-CKA synthesis in SCD is up-regulated during pathogenic vascular stress. Administration of Kyn-CKA abrogated pulmonary microvasculature occlusion in SCD mice, an important factor in lung injury development. These findings demonstrate that the up-regulation of kynurenine synthesis and its metabolism to Kyn-CKA is an adaptive response that attenuates inflammation and protects tissues.
- 1 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (26) , eabm9138
Open AccessImmunomodulatory actions of a kynurenine-derived endogenous electrophile
The up-regulation of kynurenine metabolism induces immunomodulatory responses via incompletely understood mechanisms. We report that increases in cellular and systemic kynurenine levels yield the electrophilic derivative kynurenine-carboxyketoalkene (Kyn-CKA), as evidenced by the accumulation of thiol conjugates and saturated metabolites. Kyn-CKA induces NFE2 like bZIP transcription factor 2– and aryl hydrocarbon receptor–regulated genes and inhibits nuclear factor κB– and NLR family pyrin domain containing 3-dependent proinflammatory signaling. Sickle cell disease (SCD) is a hereditary hemolytic condition characterized by basal inflammation and recurrent vaso-occlusive crises. Both transgenic SCD mice and patients with SCD exhibit increased kynurenine and Kyn-CKA metabolite levels. Plasma hemin and kynurenine concentrations are positively correlated, indicating that Kyn-CKA synthesis in SCD is up-regulated during pathogenic vascular stress. Administration of Kyn-CKA abrogated pulmonary microvasculature occlusion in SCD mice, an important factor in lung injury development. These findings demonstrate that the up-regulation of kynurenine synthesis and its metabolism to Kyn-CKA is an adaptive response that attenuates inflammation and protects tissues.